Gino Santini's most recent trade in Collegium Pharmaceutical Inc was a trade of 15,000 Stock Option (Right to Purchase) done . Disclosure was reported to the exchange on Aug. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 15,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.45 per share. | 15 Aug 2025 | 15,000 | 100,447 (0%) | 0% | 13.5 | 201,750 | Common Stock |
| Collegium Pharmaceutical Inc | Gino Santini | Director | Sale of securities on an exchange or to another person at price $ 37.19 per share. | 15 Aug 2025 | 5,405 | 95,042 (0%) | 0% | 37.2 | 201,018 | Common Stock |
| Compass Pathways Plc - ADR | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 39,000 | 39,000 | - | - | Share Option (Right to Buy) | |
| Collegium Pharmaceutical Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 9,791 | 85,447 (0%) | 0% | 0 | Common Stock | |
| Compass Pathways Plc - ADR | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 52,000 | 52,000 | - | - | Share Option (Right to Buy) | |
| Collegium Pharmaceutical Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 7,693 | 75,656 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 12,547 | 12,547 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 8,111 | 31,756 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 9,792 | 67,963 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 57,867 (0%) | 0% | - | Ordinary Shares | |
| Intercept Pharmaceuticals Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 12,790 | 12,790 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 7,737 | 23,645 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 14,035 | 58,171 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 50,472 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 3,913 | 3,913 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Gino Santini | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.56 per share. | 28 Apr 2022 | 1,658 | 48,814 (0%) | 0% | 98.6 | 163,412 | Ordinary Shares |
| Intercept Pharmaceuticals Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 12,089 | 12,089 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,029 | 15,908 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 9,941 | 44,136 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Gino Santini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 50,606 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Gino Santini | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.62 per share. | 29 Apr 2021 | 4,357 | 46,249 (0%) | 0% | 94.6 | 412,259 | Ordinary Shares |
| Horizon Therapeutics Plc | Gino Santini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,223 | 4,223 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Gino Santini | Director | Sale of securities on an exchange or to another person at price $ 91.47 per share. | 01 Mar 2021 | 12,000 | 23,795 (0%) | 0% | 91.5 | 1,097,600 | Ordinary Shares |